Enavate Sciences GP, LLC 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
ES Enavate Sciences GP, LLC | Institutional Filer | ▼ 30.64% | $351.5M | 7 |
Current Portfolio Holdings
Showing all 7 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | SION | Sionna Therapeutics, Inc. | Healthcare | 2.5M | $99.3M | 28.26% |
| 2 | IMNM | Immunome, Inc. | Healthcare | 3.6M | $79.0M | 22.48% |
| 3 | ZBIO | Zenas BioPharma, Inc. | Healthcare | 3.9M | $76.6M | 21.80% |
| 4 | CMPX | Compass Therapeutics, Inc. | Healthcare | 7.8M | $41.2M | 11.72% |
| 5 | BBOT | BridgeBio Oncology Therapeutics Inc. | Healthcare | 2.6M | $23.5M | 6.69% |
| 6 | UPB | UPSTREAM BIO INC | — | 2.5M | $22.1M | 6.30% |
| 7 | CAMP | CAMP4 Therapeutics Corporation | Healthcare | 2.2M | $9.7M | 2.75% |
Showing 1 to 7 of 7 holdings